These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17201120)

  • 1. Endogenous expression of CD80 co-stimulatory molecule facilitates in vivo tumor regression of oral squamous carcinoma.
    Thomas GR; Wen J
    Anticancer Res; 2006; 26(6B):4093-101. PubMed ID: 17201120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma.
    Tsushima F; Tanaka K; Otsuki N; Youngnak P; Iwai H; Omura K; Azuma M
    Oral Oncol; 2006 Mar; 42(3):268-74. PubMed ID: 16271509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma.
    Tirapu I; Huarte E; Guiducci C; Arina A; Zaratiegui M; Murillo O; Gonzalez A; Berasain C; Berraondo P; Fortes P; Prieto J; Colombo MP; Chen L; Melero I
    Cancer Res; 2006 Feb; 66(4):2442-50. PubMed ID: 16489051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
    Chen PW; Uno T; Ksander BR
    Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma.
    Thomas GR; Chen Z; Enamorado I; Bancroft C; Van Waes C
    Int J Cancer; 2000 May; 86(3):368-74. PubMed ID: 10760825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immunological antitumor effects by adenovirus-mediated gene transfer of B7-1 in a murine squamous cell carcinoma cell line.
    Hoshitani Y; Ishida H; Otsuki N; Shirakawa T; Gotoh A; Nibu K
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):270-5. PubMed ID: 17372085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of major histocompatibility complex class II and costimulatory molecules in oral carcinomas in vitro.
    Villarroel-Dorrego M; Speight PM; Barrett AW
    Med Oral Patol Oral Cir Bucal; 2005; 10(3):188-95. PubMed ID: 15876961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma.
    Thomas GR; Chen Z; Oechsli MN; Hendler FJ; Van Waes C
    Int J Cancer; 1999 Jul; 82(3):377-84. PubMed ID: 10399955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80 gene therapy for lymph node involvement by gastric carcinoma.
    Kosaka K; Yashiro M; Sakate Y; Tanaka H; Sunami T; Ohira M; Hirakawa K
    Int J Oncol; 2004 Nov; 25(5):1319-25. PubMed ID: 15492821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line.
    Lee BK; Kim MJ; Jang HS; Lee HR; Ahn KM; Lee JH; Choung PH; Kim MJ
    In Vivo; 2008; 22(5):593-7. PubMed ID: 18853752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
    Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cervical lymph node metastasis model of squamous cell carcinoma in the oral cavity in mice.
    Sun R; Zhang JG; Guo CB
    Chin Med J (Engl); 2008 Oct; 121(19):1891-5. PubMed ID: 19080119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.